Back to Home
T
Contributor Profile
TND Health Desk
Contributor
6 articles0 followers1 views
Professional journalist and contributor at The New Dispensation, specializing in Health coverage.
Curated Articles Feed
A dedicated collection of reporting, commentary, and analysis by TND Health Desk.

BreakingHealth
Moderna and Merck Say Personalized mRNA Melanoma Vaccine Succeeded in Large Trial, Opening 'New Chapter in Cancer Care'
A personalized mRNA vaccine combined with Keytruda reduced melanoma recurrence and spread in a late-stage trial of 1,137 patients, sending Moderna shares up 160% as the companies prepare to file for approval within months.
TND Health DeskAug 21, 2026
